Figure 3.
Clinical efficacy. A, Kaplan-Meier curves for improvement in all targeted symptoms for 2 consecutive days in the camostat and placebo arms. B, Kaplan-Meier curves for hospitalization and death by treatment arm through day 28.
Clinical efficacy. A, Kaplan-Meier curves for improvement in all targeted symptoms for 2 consecutive days in the camostat and placebo arms. B, Kaplan-Meier curves for hospitalization and death by treatment arm through day 28.
